tiprankstipranks
Advertisement
Advertisement

ESPR Stock Latest News

Esperion clears key U.S. antitrust hurdle for merger
Company AnnouncementsEsperion clears key U.S. antitrust hurdle for merger
16d ago
8K
ESPR
Esperion Gains German Approval for ArchiMed Acquisition Deal
PremiumCompany Announcements
Esperion Gains German Approval for ArchiMed Acquisition Deal
23d ago
8K
ESPR
Esperion Shareholders Approve Directors, Pay, and Equity Plan
PremiumCompany Announcements
Esperion Shareholders Approve Directors, Pay, and Equity Plan
1M ago
8K
ESPR
Esperion presents new data from CLEAR Outcomes, CLEAR Phase 2 study
PremiumThe Fly
Esperion presents new data from CLEAR Outcomes, CLEAR Phase 2 study
1M ago
ESPR
Esperion Therapeutics’ 10-Q Forward-Looking Statements Highlight Significant Uncertainty and Investor Risk
PremiumCompany Announcements
Esperion Therapeutics’ 10-Q Forward-Looking Statements Highlight Significant Uncertainty and Investor Risk
2M ago
ESPR
EXE, IP, ESPR, CMPS, TNXP Trending With Analysts
PremiumWeekend UpdatesEXE, IP, ESPR, CMPS, TNXP Trending With Analysts
2M ago
IP
EXE
ESPR Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
ESPR Earnings this Week: How Will it Perform?
2M ago
ESPR
Esperion downgraded to Hold from Buy at Needham
Premium
The Fly
Esperion downgraded to Hold from Buy at Needham
2M ago
ESPR
AI Models Turn More Positive on Esperion as ARCHIMED Buyout Drives Upside
PremiumAI Analyst Ratings
AI Models Turn More Positive on Esperion as ARCHIMED Buyout Drives Upside
2M ago
ESPR
Esperion Stock Surges Onto Analysts’ Trending Radar
PremiumWeekend Updates
Esperion Stock Surges Onto Analysts’ Trending Radar
2M ago
ESPR
Esperion downgraded to Hold from Buy at Jefferies
PremiumThe Fly
Esperion downgraded to Hold from Buy at Jefferies
2M ago
ESPR
Esperion downgraded to Neutral from Overweight at Piper Sandler
PremiumThe Fly
Esperion downgraded to Neutral from Overweight at Piper Sandler
2M ago
ESPR
Esperion agrees to $1.1 billion ARCHIMED buyout
PremiumCompany AnnouncementsEsperion agrees to $1.1 billion ARCHIMED buyout
2M ago
8K
ESPR
Midday Fly By: Apple reports Q2 beat, oil majors post mixed results
Premium
The Fly
Midday Fly By: Apple reports Q2 beat, oil majors post mixed results
2M ago
AN
BP
Esperion downgraded to Neutral from Buy at H.C. Wainwright
Premium
The Fly
Esperion downgraded to Neutral from Buy at H.C. Wainwright
2M ago
ESPR
Esperion downgraded to Neutral from Overweight at Cantor Fitzgerald
PremiumThe Fly
Esperion downgraded to Neutral from Overweight at Cantor Fitzgerald
2M ago
ESPR
Esperion to be acquired by Archimed for $3.16 per share, one CVR
PremiumThe Fly
Esperion to be acquired by Archimed for $3.16 per share, one CVR
2M ago
ESPR
Esperion Therapeutics: Reinforced Buy Rating on Strengthened Investment Story and Conference-Driven Upside Catalysts
PremiumRatings
Esperion Therapeutics: Reinforced Buy Rating on Strengthened Investment Story and Conference-Driven Upside Catalysts
3M ago
ESPR
Esperion Completes Corstasis Acquisition, Expands Cardiovascular Portfolio
PremiumCompany Announcements
Esperion Completes Corstasis Acquisition, Expands Cardiovascular Portfolio
3M ago
8K
ESPR
Esperion, Athyrium Capital enter $50M royalty financing agreement
PremiumThe FlyEsperion, Athyrium Capital enter $50M royalty financing agreement
3M ago
ESPR
Esperion Therapeutics Earnings Call Signals Expansion
Premium
Company Announcements
Esperion Therapeutics Earnings Call Signals Expansion
3M ago
ESPR
Esperion Therapeutics: CLEAR Outcomes Stroke Data and Commercial Momentum Underscore Buy-Rated Cardiovascular Franchise
Premium
Ratings
Esperion Therapeutics: CLEAR Outcomes Stroke Data and Commercial Momentum Underscore Buy-Rated Cardiovascular Franchise
3M ago
ESPR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >